BioXcel Therapeutics (BTAI) Shares Outstanding (Entity) (2017 - 2026)
Powered by 
Analysis
BioXcel Therapeutics (BTAI) Shares Outstanding (Entity) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 210.97 Bn | 196.98 Bn | 7.24 Bn | 540.60 Mn |
| 2 | Gilead Sciences | 180.98 Bn | 177.80 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.09 Bn | 124.24 Bn | 2.84 Bn | 253.35 Mn |
| 4 | Regeneron Pharmaceuticals | 82.56 Bn | 74.57 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.71 Bn | 56.53 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.60 Bn | 49.46 Bn | 52.00 Mn | 399.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.02 Bn | 30.71 Bn | 992.69 Mn | 133.73 Mn |
| 8 | Biogen | 31.25 Bn | 29.97 Bn | 1.96 Bn | 147.75 Mn |
| 9 | Roivant Sciences | 29.76 Bn | 29.76 Bn | 1.16 Mn | 722.67 Mn |
| 10 | BioXcel Therapeutics | 2.19 Mn | 2.19 Mn | 160,000.00 | 31.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.31 Mn |
| Mar 31, 2026 | 27.08 Mn |
| Dec 31, 2025 | 12.21 Mn |
| Sep 30, 2025 | 14.20 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.83 Mn |
| Jun 30, 2023 | 1.83 Mn |
| Mar 31, 2023 | 1.82 Mn |
| Dec 31, 2022 | 1.76 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 1.75 Mn |